Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Multiparametric immune profiling in HPV– oral squamous cell cancer
Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox
Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox
View: Text | PDF
Research Article Immunology Oncology

Multiparametric immune profiling in HPV– oral squamous cell cancer

  • Text
  • PDF
Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV– OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

Authors

Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger, Bernard A. Fox

×

Figure 14

The cumulative suppression index is a highly indicative prognostic marker superior to the prognostic index of the single markers.

Options: View larger image (or click on image) Download as PowerPoint
The cumulative suppression index is a highly indicative prognostic marke...
(A) Kaplan-Meier curve showing the influence of the combined cytoplasmatic expression levels of β2m, HC, and LMP10 on OS. Patients were separated as above or below the median for each marker. A score of 0 represents below-median cutoff expression, and a score of 3 represents high expression for all three APM components. (B) Combining suppression indices (SI) from tumor and stroma to obtain cumulative suppression index (CSI). Each column represents FoxP330μmCD8n and PD-L130μmCD8n in tumor and stroma, with red indicating above-median cutoff, marking increased suppression. (C) Analysis of the entire cohort demonstrates the highly significant stepwise reduction of OS based on an increasing CSI, with 0 representing the lowest and 4 representing the most suppression relative to CD8+ T cells. (D) Kaplan-Meier curve for the CSI for patients with stage I–III disease. (E) Kaplan-Meier curve for the CSI for patients with stage IV disease. (F) Analysis of CSI in combination with the 3 APM components, demonstrating a highly significant stepwise reduction of OS based on an increasing score. A score of 0 represents low suppression and low cytoplasmatic APM expression (below-median cutoff); a score of 7 represents high (above-median) cutoff for all 7 categories. (A and C–F) Log-rank statistics were performed to determine significance. The top P value refers to all comparisons, the bottom P value refers to the difference between the lowest and highest score. n = 119 (A, C, and F); 59 (D); E = 60 (E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts